163 related articles for article (PubMed ID: 33418569)
1. Coccidioidomycosis in patients with various inflammatory disorders treated with tumor necrosis factor α inhibitors.
Delafield NL; Mesbah Z; Lacy CR; Panicker RR; Pasha SF; Mertz LE; Yiannias JA; Blair JE
Med Mycol; 2021 Jul; 59(7):720-727. PubMed ID: 33418569
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Screening for Coccidioidomycosis in Recipients of Inhibitors of Tumor Necrosis Factor α.
Choi K; Deval N; Vyas A; Moran C; Cha SS; Mertz LE; Pasha SF; Yiannias JA; Blair JE
Clin Infect Dis; 2019 Mar; 68(6):1024-1030. PubMed ID: 30084971
[TBL] [Abstract][Full Text] [Related]
3. Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis.
Garrett AL; Cha SS; Wack E; Blair JE
Infection; 2017 Aug; 45(4):539-543. PubMed ID: 28577242
[TBL] [Abstract][Full Text] [Related]
4. Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs).
Paul D; Patil D; McDonald L; Patel V; Lobo F
J Med Econ; 2020 Sep; 23(9):1025-1031. PubMed ID: 32427547
[No Abstract] [Full Text] [Related]
5. Risk of Serious Bacterial Infection Associated With Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Inflammatory Bowel Disease.
Lee WJ; Lee TA; Calip GS; Suda KJ; Briars L; Schumock GT
Inflamm Bowel Dis; 2018 Mar; 24(4):883-891. PubMed ID: 29562275
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Tumor Necrosis Factor-Alpha Inhibitors on Uveitis in Patients with Ankylosing Spondylitis.
Lee S; Park YJ; Lee JY
J Korean Med Sci; 2019 Nov; 34(42):e278. PubMed ID: 31674159
[TBL] [Abstract][Full Text] [Related]
7. Use of tumor necrosis factor-alpha inhibitors during pregnancy among women who delivered live born infants.
Eworuke E; Panucci G; Goulding M; Neuner R; Toh S
Pharmacoepidemiol Drug Saf; 2019 Mar; 28(3):296-304. PubMed ID: 30430682
[TBL] [Abstract][Full Text] [Related]
8. Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases.
Lopetuso LR; Cuomo C; Mignini I; Gasbarrini A; Papa A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175894
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.
Nesbitt A; Fossati G; Bergin M; Stephens P; Stephens S; Foulkes R; Brown D; Robinson M; Bourne T
Inflamm Bowel Dis; 2007 Nov; 13(11):1323-32. PubMed ID: 17636564
[TBL] [Abstract][Full Text] [Related]
10. Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists.
Bergstrom L; Yocum DE; Ampel NM; Villanueva I; Lisse J; Gluck O; Tesser J; Posever J; Miller M; Araujo J; Kageyama DM; Berry M; Karl L; Yung CM
Arthritis Rheum; 2004 Jun; 50(6):1959-66. PubMed ID: 15188373
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and outcomes of culture-proven acute Coccidioides spp. infection in San Diego, California, United States.
Jenks JD; Reed SL; Hoenigl M
Mycoses; 2020 Jun; 63(6):553-557. PubMed ID: 32176829
[TBL] [Abstract][Full Text] [Related]
12. Coccidioidomycosis in rheumatology patients: incidence and potential risk factors.
Mertz LE; Blair JE
Ann N Y Acad Sci; 2007 Sep; 1111():343-57. PubMed ID: 17363440
[TBL] [Abstract][Full Text] [Related]
13. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
14. Coccidioidomycosis in elderly persons.
Blair JE; Mayer AP; Currier J; Files JA; Wu Q
Clin Infect Dis; 2008 Dec; 47(12):1513-8. PubMed ID: 18990061
[TBL] [Abstract][Full Text] [Related]
15. Role of Tumor Necrosis Factor-α Inhibitors in the Treatment and Occurrence of Acne: A Systematic Review.
Sandoval AGW; Vaughn LT; Huang JT; Barbieri JS
JAMA Dermatol; 2023 May; 159(5):504-509. PubMed ID: 36930143
[TBL] [Abstract][Full Text] [Related]
16. Coccidioides (spherulin) skin testing in patients with pulmonary coccidioidomycosis in an endemic region†.
Mafi N; Murphy CB; Girardo ME; Blair JE
Med Mycol; 2020 Jul; 58(5):626-631. PubMed ID: 31578560
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions.
Calip GS; Patel PR; Adimadhyam S; Xing S; Wu Z; Sweiss K; Schumock GT; Lee TA; Chiu BC
Int J Cancer; 2018 Sep; 143(5):1062-1071. PubMed ID: 29603214
[TBL] [Abstract][Full Text] [Related]
18. Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature.
Fitterer C; Berg Z; Halfdanarson TR; Vikram HR; Kusne S; Orenstein R; Seville MT; Blair JE
Mycopathologia; 2016 Dec; 181(11-12):787-798. PubMed ID: 27492230
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.
Nguyen C; Barker BM; Hoover S; Nix DE; Ampel NM; Frelinger JA; Orbach MJ; Galgiani JN
Clin Microbiol Rev; 2013 Jul; 26(3):505-25. PubMed ID: 23824371
[TBL] [Abstract][Full Text] [Related]
20. Use of Tumor Necrosis Factor-Alpha Inhibitors in Children and Young Adults With Juvenile Idiopathic Arthritis or Rheumatoid Arthritis.
Lee WJ; Briars L; Lee TA; Calip GS; Suda KJ; Schumock GT
Pharmacotherapy; 2016 Dec; 36(12):1201-1209. PubMed ID: 27779782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
